Mark A. Velleca Black Diamond Therapeutics, Inc. (BDTX) insider trading activity

BDTX Quotes by TradingView

Mark A. Velleca is PRESIDENT & CEO of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 121,522 shares of BDTX, which is worth approximately $277,070. The most recent transaction as insider was on Jan 30, 2025, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K
161.21% 3M change
161.21% 12M change
Total Value Held $277,070

Mark A. Velleca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2025
BUY
Grant, award, or other acquisition
-
75,000 Added 38.16%
121,522 Common Stock
Sep 15 2023
BUY
Grant, award, or other acquisition
$18,748 $3.6 p/Share
5,208 Added 10.07%
46,522 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
$18,750 $2.1 p/Share
8,929 Added 17.77%
41,314 Common Stock
Mar 16 2023
BUY
Grant, award, or other acquisition
$18,750 $1.67 p/Share
11,228 Added 25.74%
32,385 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
$12,636 $1.5 p/Share
8,424 Added 28.48%
21,157 Common Stock
Sep 16 2022
BUY
Grant, award, or other acquisition
$11,250 $2.62 p/Share
4,294 Added 25.22%
12,733 Common Stock
Jun 17 2022
BUY
Grant, award, or other acquisition
$11,250 $2.03 p/Share
5,542 Added 39.64%
8,439 Common Stock
Mar 18 2022
BUY
Grant, award, or other acquisition
$8,749 $3.02 p/Share
2,897 Added 50.0%
2,897 Common Stock

Also insider at

GTHX
G1 Therapeutics, Inc. Healthcare
MAV

Mark A. Velleca

PRESIDENT & CEO
Research Triangle Park, NC

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BDTX